About this trial
This study will use community-informed advertisements and messages through electronic methods to recruit and retain a large (N=3,200), diverse national sample of high-risk young men who have sex with men (YMSM) and non-binary individuals that are assigned male sex at birth, 16-29 years of age to determine the efficacy of the MyPEEPS Mobile intervention on reduced incident HIV infections in comparison to a standard of care condition and to examine the degree to which reduced incident HIV infections occurs in the context of potential multilevel moderators and conceptual mediators. This is key to advancing HIV prevention among HIV-negative US persons at extremely high-risk for HIV seroconversion.
Eligibility criteria
Qualifiers
Be between 16-29 years of age;
Sex assigned at birth is male and identify gender as male or non-binary;
Understand and read English;
Live within US and its territories;
Disqualifiers
Individuals who identify as transgender
Trial design
Treatments tested in this trial
- MyPEEPS Mobile
Treatment groups
Sponsors and collaborators
Columbia University
Lead sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Collaborator
Northwestern University
Collaborator
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborator